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manage chronic obstructive pulmonary
disease (INTEGRATED): study protocol
Lisa Pagano1, Zoe McKeough1, Sally Wootton1,2, Stephen Crone2, Deborah Pallavicini3, Andrew S. L. Chan4,5,
Sriram Mahadev4,5, Nicholas Zwar6 and Sarah Dennis1,7,8,9*
Abstract
Background: Chronic obstructive pulmonary disease (COPD) contributes significantly to mortality, hospitalisations
and health care costs worldwide. There is evidence that the detection, accurate diagnosis and management of
COPD are currently suboptimal in primary care. Physiotherapists are well-trained in cardiorespiratory management
and chronic care but are currently underutilised in primary care. A cardiorespiratory physiotherapist working in
partnership with general practitioners (GPs) has the potential to improve quality of care for people with COPD.
Methods: A prospective pilot study will test the feasibility of an integrated model of care between GPs and
physiotherapists to improve the diagnosis and management of people with COPD in primary care. Four general
practices will be selected to work in partnership with four physiotherapists from their local health district. Patients
at risk of developing COPD or those with a current diagnosis of COPD will be invited to attend a baseline
assessment with the physiotherapist, including pre- and post-bronchodilator spirometry to identify new cases of
COPD or confirm a current diagnosis and stage of COPD. The intervention for those with COPD will involve the
physiotherapist and GP working in partnership to develop and implement a care plan involving the following
tailored to patient need: referral to pulmonary rehabilitation (PR), physical activity counselling, medication review,
smoking cessation, review of inhaler technique and education. Process outcomes will include the number of
people invited and reviewed at the practice, the proportion with a new diagnosis of COPD, the number of patients
eligible and referred to PR and the number who attended PR. Patient outcomes will include changes in symptoms,
physical activity levels, smoking status and self-reported exacerbations.
Discussion: If feasible, we will test the integration of physiotherapists within the primary care setting in a cluster
randomised controlled trial. If the model improves health outcomes for the growing numbers of people with
COPD, then it may provide a GP-physiotherapist model of care that could be tested for other chronic conditions.
Trial registration: ANZCTR, ACTRN12619001127190. Registered on 12 August 2019—retrospectively registered.
Keywords: COPD, Primary care, Pulmonary rehabilitation, Physical activity, Screening, Physiotherapy/physical
therapy
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Background
Chronic obstructive pulmonary disease (COPD) contrib-
utes significantly to mortality, hospitalisations and health
care costs worldwide [1]. In Australia alone, COPD con-
tributed to 4.5% of all deaths [2] and was the principal
diagnosis for 66,540 hospitalisations for people aged 45
and over in 2015 [3]. COPD is the 11th most commonly
managed chronic condition in Australian general prac-
tice [4]. The COPD-X Concise Guide for Primary Care
identifies general practice as an ideal setting for the diag-
nosis and management of COPD [5]; however, despite
best available evidence-based recommendations, COPD
remains under-diagnosed, misdiagnosed and manage-
ment has been suboptimal in primary care. For example,
the Burden of Obstructive Lung Disease Survey found
that the prevalence of airflow limitation (GOLD stage II
or higher) in Australians 40 years and over was 7.5%,
whereas the prevalence of doctor-diagnosed COPD in
the same population was only 5.2% [6].
High-quality spirometry testing is one way to improve
the diagnosis of COPD in primary care [5, 7] yet evi-
dence indicates that the use of spirometry in general
practice is low [8–10]. There are multiple factors con-
tributing to the suboptimal use of spirometry in primary
care. Firstly, GPs are not adequately reimbursed by
Medicare to undertake pre- and post-bronchodilator
spirometry with current reimbursement being only
$34.95 from the Medicare Benefits Schedule which can
only be claimed once in any 12-month period. A further
barrier is that some GPs and practice nurses (PNs) lack
confidence in the interpretation of spirometry [11] with
one study reporting that GPs and PNs misinterpreted
spirometry in 30% of cases [12].
Improvement in the diagnosis of COPD could be
achieved through case-finding methods. This involves
the identification of ‘high-risk patients’ and utilising
standardised screening questionnaires in addition to
spirometry. Previous studies have targeted people over
the age of 40 years who are current or ex-smokers with a
10-year or more pack history and have focused on ups-
killing GPs, PNs or research assistants at performing
these screening techniques. These methods have been
shown to be effective with the identification of new cases
of COPD ranging from 4 to 27%, as well as identifying a
high rate of misdiagnosis [12–14].
Once COPD has been confirmed and pharmacological
management optimised, one of the most effective non-
pharmacological interventions for individuals with
COPD is pulmonary rehabilitation (PR). PR has been
shown to lead to improvements in exercise tolerance,
dyspnoea, depression and overall health-related quality
of life [15–18]. However, despite strong international
recommendations, referral to PR from healthcare profes-
sionals is low. It is estimated that only 3–16% of eligible
patients are referred to PR and even fewer people (1–
2%) actually receive this intervention [16, 19]. In particu-
lar, referral rates from primary care are low with one
study reporting only 5% of eligible patients were referred
to PR by general practitioners [20]. The barriers to refer-
ral and attendance at PR are well known. These include
low awareness and knowledge of PR and the benefits of
PR, low knowledge of the referral process and a lack of
persuasive health professional communication [21–23].
Current guidelines also recommend the use of multidis-
ciplinary care plans in the management of patients with
COPD [5]. Multidisciplinary care plans, initiated by GPs,
anticipate the wide range of long-term needs of patients
with COPD and have been found to improve exercise
capacity and health-related quality of life and reduce
hospitalisation [24–26]. However, some studies have
found that GPs need more support to develop and im-
plement multidisciplinary care plans in some chronic
conditions such as asthma [27, 28].
The issues surrounding the management of COPD in
primary care are complex, and there is a need for alterna-
tive strategies to improve outcomes for patients with
COPD. Zwar et al. (2016) tested a GP-nurse partnership
approach in the management of newly diagnosed COPD
and found no difference in outcomes compared to usual
care [12]. Furthermore, they found that some PNs still
lacked confidence in the diagnosis and management of
COPD despite additional training [11]. One alternative
method could be to utilise multi-component inter-
disciplinary management which, in a COPD population,
has shown improvements in some patient outcomes in-
cluding disease-specific quality of life [29, 30], patient self-
reported physical activity levels [31] and exercise capacity
[30]. A Cochrane review has reported a reduction in hos-
pital admissions and hospital days per person in favour of
the inter-disciplinary management approach [30].
Physiotherapists play an important role in respiratory
disease management in Australian hospitals, particularly
in coordinating PR programmes and in providing physical
activity advice. Physiotherapy students in Australia under-
take extensive training in cardiopulmonary physiotherapy.
This training includes the use and interpretation of spir-
ometry, conducting exercise testing for people with re-
spiratory disease and exercise prescription within a PR
programme. Physiotherapists are, therefore, well posi-
tioned to work in partnership with GPs to better manage
patients with chronic lung disease but are currently un-
derused in this role in primary care. Physiotherapy ser-
vices, as a first point of contact, have been shown to be
safe, effective and well received by patients with musculo-
skeletal complaints [32, 33]. There is currently no pub-
lished literature on a GP-physiotherapist partnership
model in primary care in an Australian setting to improve
identification and management of COPD.
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Study aims and hypothesis
The primary aim of the INTEGRATED study (InNova-
TivE Gp-physiotheRapist pArTnErship for copD) is to
determine the feasibility and acceptability of this inte-
grated model of GP and physiotherapist partnership.
The secondary aims are to (1) produce high-quality spir-
ometry with accurate interpretation to both identify new
cases of COPD and determine the stage of severity for
known cases of COPD, (2) increase general practice re-
ferrals to pulmonary rehabilitation for people that meet
the COPD-X guidelines criteria for referral [5], (3) in-
crease physical activity levels in people with COPD at 3
months compared to baseline and (4) increase smoking
cessation in those who are smokers at baseline.
The INTEGRATED study hypothesises that a GP and
physiotherapist model of care will be a feasible and ac-
ceptable way to improve the diagnosis and management
of people with COPD. This will be achieved through
more accurate spirometry interpretation, at least 90% of
participants who meet the COPD-X guidelines for refer-
ral to PR being referred to a programme, an increase in
physical activity levels by participants at 3 months com-
pared to baseline, and at least 50–75% of participants
have attended or commenced a smoking cessation
programme at 3 months after their baseline visit.
Methods
The INTEGRATED study is a before and after feasibility
study within the ‘health services’ research domain with the
aim of trialling a new model of care intended for use in a
larger cluster randomised controlled trial (RCT). The
protocol has followed the TIDieR (Template for Interven-
tion Description and Replication framework) Framework.
The study is being conducted in metropolitan Sydney,
Australia, and commenced recruitment in October 2018
with the aim of continuing to review participants into June
2020. The research and data collection plan is summarised
in Fig. 1. A minimum of four general practices will be re-
cruited to the study from a local Primary Health Network
(PHN). Physiotherapists from the rehabilitation service of
the corresponding Local Health District (LHD) will run a




General practices will be eligible if they use compu-
terised clinical software, have a room available for use by
the physiotherapist and are interested in an integrated
GP-physiotherapist partnership model for COPD man-
agement. Where possible, general practices will be
chosen that meet the PHN strategic directions for inte-
grated care and are close to one of the PR programmes
provided by the LHD.
Patients
The INTEGRATED study will target two groups of pa-
tients—new cases of COPD and those with existing
COPD. The inclusion criteria have been successfully
used in a previous primary care COPD case-finding
study [12].
New cases of COPD
Patients will be eligible if they have attended the practice
at least twice with one visit in the preceding 12months,
are aged 40 years or over and have a documented history
of smoking (current or former smoker) in their medical
notes. A history of current smoking or past smoking will
identify those patients who are at high risk of developing
COPD.
Existing COPD
Patients will be eligible if they are aged 40 years or over,
have a recorded diagnosis of COPD or are taking medi-
cations prescribed for COPD (such as short-acting in-
haled β2 agonists (SABA), short-acting muscarinic
antagonists (SAMA), long-acting inhaled β2 agonists
(LABA), long-acting muscarinic antagonists (LAMA),
combination of LABA/LAMA and inhaled corticoste-
roids), and they have visited the practice in the last 12
months.
Patients will be excluded if they have terminal cancer,
cognitive impairment, require home oxygen, do not
speak sufficient English or are pregnant.
Recruitment
General practice and physiotherapist recruitment
Recruitment will be conducted with assistance from the
PHN. An expression of interest will be included in the
newsletter sent to local practices. Those practices express-
ing an interest in taking part in the study will be visited by
an investigator to discuss the study and answer any ques-
tions. The practices will be provided with an information
sheet and asked to provide written consent to participate
in the study. As requested by the local ethics committee, a
contract will be prepared and signed between the LHD
and the general practices taking part in the study. This will
be forwarded to the ethics committee before the practice
starts the study. The LHD will identify a senior respiratory
physiotherapist with at least 5 years of clinical experience
in the management of chronic respiratory conditions to
partner with each of the participating general practices.
These physiotherapists are experienced senior clinicians
who have specialist knowledge within their discipline [34]
and have undergone extensive training to develop their
skill set for chronic respiratory disease management. They
will have high-level skills in spirometry including inter-
pretation, COPD management and self-management, ex-
ercise prescription and physical activity advice.
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Training of physiotherapists
All physiotherapists will receive training in case-finding
for the diagnosis of COPD. This will comprise two
workshops. This first workshop will cover the case-
finding approach for the diagnosis of COPD with per-
formance of spirometry based on the European Respira-
tory Society (ERS)/American Thoracic Society (ATS)
quality criteria and its interpretation [35] as this is essen-
tial to the accurate diagnosis and assessment of COPD
[5]. The second workshop will include training on
COPD management such as smoking cessation advice
and referral, physical activity advice and referral to pul-
monary rehabilitation if required, preparation of a care
plan with the general practice team and the processes
for the case-finding and follow-up appointments.
Patient recruitment
Potentially eligible patients will be identified from a
search of the practice electronic records of all participat-
ing general practices by either a research assistant or
trained practice staff. The resultant list will be checked
for exclusions by the GPs and /or PNs. All potentially
eligible patients will be sent an invitation from the prac-
tice inviting them to take part in the study. Those inter-
ested in the study will be asked to return the completed
form in a pre-paid envelope and to also provide written
informed consent.
Patient and public involvement statement
Patient input was obtained from the qualitative feedback
of the PELICAN study [12] and was used to refine the
Identification and recruitment of 
eligible general practices
Follow-up (One month from baseline)
Identification of eligible patients 
at risk of COPD or with a current 
diagnosis of COPD. Written 
informed consent obtained from 
participants
Physiotherapist spirometry and 
case-finding workshop
Case finding visit and baseline data 
collection  (0 months)
Follow-up (Three months from baseline)
COPD diagnosed or diagnosis confirmed COPD excluded
Fig. 1 Study and data collection processes
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model of care to determine the added value of the
physiotherapist to the primary care team. It was not pos-
sible to involve patients in the study design beyond this.
The qualitative feedback from the participants in this
pilot study will be used to further modify the interven-
tion for a larger study. We had health service involve-
ment in the setting of the study aims from the
rehabilitation service in the LHD. They were directly in-
volved in establishing the project around the priorities
for their chronic disease integration service which aimed
to engage with a less severe patient population in




All patients (new cases and existing COPD) will be re-
quired to complete the following questionnaires at base-
line: demographic questionnaire, COPD Diagnostic
Questionnaire (CDQ) [36], COPD Assessment Test
(CAT) [37], Modified Medical Research Council Dyspnoea
Scale (mMRC) [38], Patient Activation Measure (PAM)
[39, 40], Physical Activity Stages of Change Questionnaire
(PASOCQ) [41] and Active Australia Questionnaire
(AAQ) [42]. All patients will undergo pre- and post-
bronchodilator spirometry based on the ERS/ATS lung
function guidelines [35]. The physiotherapist will then de-
termine the level of obstruction for those with existing
COPD or determine whether the patient has a diagnosis
of COPD which will be based on post-bronchodilator re-
sults of a forced expiratory volume in one second (FEV1)/
forced vital capacity (FVC) < 0.7. Patients will be included
for follow-up testing in the study based on a COPD diag-
nosis from spirometry testing determined by the physio-
therapist. If spirometry appears abnormal for other
reasons, the results will be discussed with the GP and
where appropriate patients will be referred for further
testing with respiratory specialists.
Intervention
The intervention will be coordinated by the physiother-
apist at each site under the supervision of the general
practice staff. Participants will be free to decline or dis-
continue any or all of the intervention components at
any point in time.
New cases of COPD
The physiotherapist will initiate and work in partnership
with the GP and patient to develop a COPD specific GP
Management Plan (GPMP) and where necessary, Team
Care Arrangement (TCA) [43] for the participant using
the template developed from the PELICAN Study [44].
This is necessary in Australia to access Medicare subsi-
dised management by an allied health provider such as a
physiotherapist. The problems identified in the assess-
ment and the plan of action including details of specific
management will be documented. If necessary, patients
will also be referred back to the GP for review and med-
ical management as required. Patients will receive phys-
ical activity advice and counselling using the 5 A’s
approach (Ask, Advise, Assess, Assist, Arrange follow-
up) according to the Australian Physical Activity and
Sedentary Behaviour Guidelines [45] and a pedometer to
monitor their physical activity goals and guide exercise
prescription at follow-up appointments. The 5As are a
clinical tool recommended for health behaviour counsel-
ling in primary care which will enable the physiotherap-
ist to identify barriers to engaging in regular physical
activity as well as strategies to overcome these barriers
and tailor physical activity goals towards the participant.
Patients will also be referred to PR if they meet the re-
quirement according to the COPD-X guidelines [5].
These guidelines state that all patients with COPD (of
all mMRC grades) will benefit from PR and recommend
that all patients with exertional dyspnoea, those at risk
of exacerbation and following an exacerbation should be
referred to PR [5]. All current smokers will receive indi-
vidualised smoking cessation advice and support and ap-
propriate referrals will be made back to the GP as
informed by the Royal Australian College of General
Practitioners (RACGP) guidelines [46]. Participant edu-
cation booklets regarding physical activity guidelines,
smoking cessation and COPD management will also be
provided.
Existing COPD
As for new cases of COPD, the physiotherapist will re-
view the current GPMP and TCA or develop one in
partnership with the GP if there is no existing GPMP/
TCA. Patients with existing COPD will also receive
physical activity advice and counselling using the 5 A’s
approach, a pedometer and smoking cessation advice
and referral if applicable. Patients will also be referred to
PR if they meet the requirement according to the
COPD-X guidelines [5] and receive participant educa-
tion booklets regarding physical activity guidelines,
smoking cessation and COPD management.
Those without COPD on spirometry
Physical activity advice and counselling using the 5 A’s
approach will be provided according to the Australian
Physical Activity and Sedentary Behaviour Guidelines
[45]. All current smokers will receive individualised
smoking cessation advice and support and appropriate
referrals will be made back to the GP. These patients
will not return for further follow-up with the
physiotherapist.
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Follow-up assessment
All participants with existing or newly diagnosed COPD
will return for a follow-up visit with the physiotherapist
at 1 month to review current physical activity levels and
establish a physical activity goal to progress towards at 3
months. A final assessment will be conducted at 3
months to review physical activity goals and complete
questionnaires.
Outcome measures
The physiotherapist will collect demographic informa-
tion including age, gender, body mass index, employ-
ment status, education and country of birth for all
individuals who attend the respiratory clinic. Patient and
process outcomes will also be collected in people with
existing COPD and those with newly diagnosed COPD.
Data will be collected at baseline and at the 1-month
and 3-month follow-up visits so the level of change in
the outcomes following the intervention can be deter-
mined. If patients are unable to attend the appointment
at 3 months with the physiotherapist, the research assist-
ant will complete the assessment by telephone.
Primary outcomes
Feasibility outcomes A summary of the outcomes that
will be used to determine the feasibility of this health
service model on the effective identification and man-
agement of COPD can be found in Table 1. The primary
outcome measures will be number (%) identified with
obstruction from the case-finding cohort and number
(%) eligible and referred to PR programmes. The success
target for number (%) identified with obstruction will be
set at 15% as previous studies have reported rates of case
finding new diagnoses of COPD between 4 and 27%
[12–14]. International literature suggests that only 5% of
eligible patients are referred by GPs to PR [20]. We
would determine the clinics successful if 80% of eligible
participants are referred to PR by the clinics and at least
50% of those referred attend an appointment.
Acceptability of the partnership approach All the par-
ticipating GPs and physiotherapists will be asked to take
part in one semi-structured interview to explore their
experiences of providing an integrated model of care for
COPD. There will be at least four GPs and four physio-
therapists interviewed. A sample of patients (n = 20) will
also be asked to take part in semi-structured interviews
to examine their experience of being involved in the
INTEGRATED study. Themes explored will include sat-
isfaction with the programme and the effects and value
of physiotherapist input into COPD diagnosis and man-
agement. Barriers and facilitators to the integrated man-
agement approach, as well as to access and uptake of
evidence-based interventions such as PR, will also be ex-
amined. GPs and physiotherapists will be asked to reflect
on their roles in the project and how they worked to-
gether to manage people with COPD. Physiotherapists
will also be asked to reflect on their skill set and how
their skill set prepared them to be integrated into the
general practice team. All interviews will be digitally re-
corded and transcribed verbatim in preparation for the-
matic analysis.
Secondary outcomes The secondary outcome measures
are summarised in Table 2 and consist of the patient-
relevant outcomes. Health status and symptom score
will be measured by the CAT. The CAT has been shown
to be a validated tool in the assessment of disease-
related quality of life [37] with the most reliable estimate
of the minimum important difference being a change of
2 points [47]. Dyspnoea will be assessed using the
Table 1 Summary of process outcomes to determine feasibility
Existing COPD New cases of COPD
Number (%) with spirometry
completed (FEV1 and FVC data)
meeting ERS/ATS quality criteria
Number (%) with spirometry
completed (FEV1 and FVC data)
meeting ERS/ATS quality criteria
Number of known COPD patients
over 40 years in the general
practice
Number of smokers/ex-smokers
over 40 years in the general
practice
Number (%) invited to attend Number (%) invited to attend
Number (%) attended first
appointment with physiotherapist
Number (%) attended first
appointment with physiotherapist
Number (%) confirmed diagnosis
and severity
Number (%) confirmed diagnosis
and severity
Number (%) eligible for PR Number (%) eligible for PR
Number (%) referred to PR Number (%) referred to PR
Number (%) attended PR Number (%) attended PR
Table 2 Summary of patient outcomes
Existing COPD New cases of COPD
Symptom Score (CAT) Symptom Score (CAT)
Meeting physical activity guidelines
(Y/N) self-reported using AAQ
Meeting physical activity guidelines





Dyspnoea score (mMRC) Dyspnoea score (mMRC)
Patient Activation Measure (PAM) Patient Activation Measure (PAM)
Daily step count (pedometer) Daily step count (pedometer)
Smoking status Smoking status
Self-reported exacerbations Self-reported exacerbations
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mMRC [38] which is rated on a scale of 0 (‘I only get
breathless with strenuous exercise’) to 4 (‘I am too
breathless to leave the house’ or ‘I am breathless when
dressing or undressing’).
Physical activity will be measured in two ways. The
first method will be self-reported activity levels and
whether they are meeting the Australian Physical Activ-
ity and Sedentary Behaviour Guidelines [45] determined
by the AAQ. The second method is the recording of
daily steps from a pedometer which will be worn either
around the patient’s neck or in their pocket. To assist
the physiotherapist in exercise prescription, the
PASOCQ [41] will also be used to determine the partici-
pant’s readiness for change. This questionnaire consists
of 4 questions which places participant’s into one of the
five stages of change (pre-contemplation, contemplation,
preparation, action and maintenance phases).
Patient health activation will be assessed using the
PAM [40] which is a 22-item measure that assesses pa-
tient knowledge, skill and confidence for self-
management.
Hospital utilisation will be assessed through self-report
of exacerbations, hospital admissions and emergency de-
partment attendance.
The CDQ [36] will also be assessed which is an 8-item
tool developed to identify those who would benefit from
spirometry testing to avoid spending time conducting
tests on those unlikely to test positive. The sum score of
the CDQ ranges from 0 to 38 and divides subjects into
three groups of COPD likelihood: low (< 16.5), medium
(16.5–19.5) and high (> 19.5).
Sample size and feasibility We will recruit a minimum
of four general practices to the study. Based on data
from a previous study [48], it is anticipated that each
practice will identify 104 potentially eligible patients with
a diagnosis of COPD with 50% participation and 52 pa-
tients are likely to consent to take part in the study. It is
estimated that the four practices will identify a total of
1060 patients who are at risk of COPD but without a
current diagnosis. Of these, 17% (180) will attend for
spirometry and assessment and 18% [33] will receive a
new diagnosis of COPD [12].
Statistical analysis
Data will be analysed using SPSS statistical software
with a two-sided significance level set to 0.05. De-
scriptive analyses will be used to evaluate the process
outcomes. Paired t test for significance will be per-
formed to compare patient responses in the baseline
and 3-month follow-up questionnaires. Interviews
with the participating GPs, PNs and physiotherapists
will be undertaken and will be digitally recorded,
transcribed verbatim and analysed thematically. The
researchers will code the data using NVivo. We will
use the Theoretical Domains Framework to guide the
coding and analysis of the health professional tran-
scripts [49]. The patient transcripts will be coded the-
matically and triangulated with the health professional
data.
Discussion
We anticipate that the GP and physiotherapist partner-
ship will be feasible and will improve the diagnosis and
management of COPD in primary care in the participat-
ing practices. Current evidence suggests that spirometry
use in primary care is low [8–10] and misinterpretation
of spirometry results and misdiagnosis of COPD is high
[12–14]. Lack of confidence expressed by GPs and PNs
at interpreting spirometry [11] could contribute to this,
and there is also recent evidence emerging regarding
people with COPD fluctuating in and out of diagnostic
status. One study [50] found that up to one-third of
symptomatic ex-smokers with baseline obstruction on
diagnostic spirometry had shifted to non-obstructed
when routinely re-tested after 1 or 2 years. This high-
lights the difficulties surrounding diagnosis and the im-
portance of follow-up testing. We hope that including
physiotherapists with expertise in the performance and
interpretation of spirometry will improve the accuracy of
diagnosis as well as identify new cases of COPD in those
deemed ‘at risk’ of developing COPD. Studies have also
reported suboptimal referral by GPs to pulmonary re-
habilitation and poor patient attendance and completion
rates [20–23, 51, 52] which is one of the most effective
treatments for COPD. More effective management of
COPD in primary care and increased uptake of pulmon-
ary rehabilitation could lead to improvements in the
quality of care and health outcomes for people with
COPD.
In Australia, physiotherapists are highly trained in
the management of cardiorespiratory problems in sec-
ondary care. Australian physiotherapists are crucial to
the delivery of exercise training programmes including
PR, as well as providing therapies to increase sputum
production, reduce work of breathing and improve
overall ventilation. Respiratory physiotherapists in
Europe also undertake extensive training in these
areas as well as conducting and interpreting pulmon-
ary function testing [53]. Physiotherapy services, as a
first point of contact, have been shown to be effective
in patients with musculoskeletal skeletal complaints
[32] and a viable alternative to GP care. It was
suggested in another study [33] that up to 85% of
musculoskeletal complaints in a general practice in
Sweden could be managed solely by the physiotherap-
ist. Currently, there is no published research on the effect-
iveness of physiotherapists providing cardiorespiratory
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interventions in partnership with GPs and this model of
care needs further investigation within an Australian
landscape.
The INTEGRATED study will test the efficacy of a
new model of care integrating experienced cardiorespira-
tory physiotherapists with GPs to improve outcomes for
people with COPD. Proven case-finding methods in an
at-risk population will be used to identify new cases of
COPD and confirm current diagnoses, as well as imple-
ment evidence-based guidelines for COPD management.
This study targets COPD patients within a primary care
setting where the contact with potential COPD patients
with mild to moderate obstruction is greatest and where
improved care has the potential for substantial health
benefit. The process outcome measures that will be used
in this study are based on components of evidence-
based care for patients with COPD [5]. These measures
will allow us to determine the integrity of the interven-
tion and to what extent the physiotherapist was able to
support the GP in delivering best practice. Other out-
come measures used will enable us to measure the
impact of the care provided on patient-level outcomes
for example impact on health status, symptom scores,
smoking status and self-reported hospital utilisation.
The results from the qualitative interviews, particularly
feedback obtained from participants in this study, will
be used to inform and further modify the intervention
for future randomised controlled trials (RCTs). A
limitation to this study is that assessment measures
will be performed by the treating physiotherapist and
not a blinded assessor. Whilst many of the outcomes
assessed in this study are self-reported which reduces
the impact of bias, any future RCTs will have blinded
assessors.
If this model of GP physiotherapist partnership is
feasible, further research will test the effectiveness
and cost-effectiveness of this model in a RCT. This
model has the potential to inform models of care that
better integrate physiotherapists (upskilled in cardio-
thoracic physiotherapy) with GPs to improve service
delivery to the increasing numbers of people with
COPD in Australia. Furthermore, there are several
other chronic conditions such as osteoarthritis, other
musculoskeletal conditions and falls that are com-
monly encountered in primary care with effective
physiotherapy interventions. This model of care for
COPD could provide a template for integrating phys-
iotherapists more effectively into the general practice
team to inform other models of care and improve
outcomes for people with these chronic conditions.
Currently, there is no research evidence for physiothera-
pists and GPs working in partnership in this way in
Australia so this project will provide the first examination
of this integrated care approach.
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TIDieR framework and demonstrates how this protocol adheres to it.
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